AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 263: G544-G550, 1992;
0193-1857/92 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mosca, P.
Right arrow Articles by Groszmann, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mosca, P.
Right arrow Articles by Groszmann, R. J.

AJP - Gastrointestinal and Liver Physiology, Vol 263, Issue 4 544-G550, Copyright © 1992 by American Physiological Society

ARTICLES

Pharmacology of portal-systemic collaterals in portal hypertensive rats: role of endothelium

P. Mosca, F. Y. Lee, A. J. Kaumann and R. J. Groszmann
Hepatic Hemodynamic Laboratory, Veterans Affairs Medical Center, West Haven, Connecticut 06516.

The portal-systemic collateral circulation of portal hypertensive rats was studied. The collaterals were perfused through the mesenteric vein with Krebs solution, which was allowed to escape through the jugular veins. The portal-collateral resistance can be quantitated from slopes of the pressure-flow relationships. In collaterals perfused at constant flow, both norepinephrine (NE) and 5-hydroxytryptamine (5-HT) increased the perfusion pressure. Phentolamine caused surmountable antagonism of the constrictor effects of NE, suggesting an involvement of alpha-adrenoceptors. The effects of 5-HT were competitively blocked by the 5-HT2 receptor-selective antagonist ICI 169,369. Isoproterenol dilated NE-preconstricted collaterals. The effect of isoproterenol was blocked by propranolol, demonstrating that the effect was mediated by beta-adrenoceptors. Acetylcholine (ACh) dilated NE-preconstricted collaterals. The dilatation effect of ACh was absent in collaterals in which the endothelium was removed. The competitive inhibitor of the nitric oxide synthase, N omega-nitro-L-arginine (L-NNA), increased collateral resistance and prevented the ACh-induced dilatation of the collaterals. The constrictor response to L-NNA and the blockade of the ACh-induced relaxation by both L-NNA and removal of endothelium are consistent with an involvement of nitric oxide. This experimental model can thus be used to explore the pathophysiological and the pharmacological properties of the collateral venous bed in portal hypertensive states.


This article has been cited by other articles:


Home page
 GutHome page
L Bellis, E Moitinho, J G Abraldes, M Graupera, J C Garcia-Pagan, J Rodes, and J Bosch
Acute propranolol administration effectively decreases portal pressure in patients with TIPS dysfunction
Gut, January 1, 2003; 52(1): 130 - 133.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
L DAGHER and K MOORE
The hepatorenal syndrome
Gut, November 1, 2001; 49(5): 729 - 737.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Munoz, A. Albillos, M. Perez-Paramo, I. Rossi, and M. Alvarez-Mon
Factors mediating the hemodynamic effects of tumor necrosis factor-alpha in portal hypertensive rats
Am J Physiol Gastrointest Liver Physiol, March 1, 1999; 276(3): G687 - G693.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P.-Y. Martin, P. Gines, and R. W. Schrier
Nitric Oxide as a Mediator of Hemodynamic Abnormalities and Sodium and Water Retention in Cirrhosis
N. Engl. J. Med., August 20, 1998; 339(8): 533 - 541.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online